SELLAS LIFE SCIENCES GROUP, INC WARRANT TO PURCHASE COMMON STOCKSELLAS Life Sciences Group, Inc. • March 6th, 2019 • Pharmaceutical preparations • New York
SELLAS Life Sciences Group, Inc., a corporation organized under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the six-month anniversary of the Issuance Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ( ) fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • March 6th, 2019 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of March 6, 2019, is by and between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
